Erratum to: Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be? (Journal of Nuclear Cardiology (2012) 19(5) (1026–1043), (S107135812303180X), (10.1007/s12350-012-9593-y));A 20th ASNC Anniversary Article Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be?

Journal of Nuclear Cardiology

Volumn 19, Issue 5, 2012, Pages 1026-1043

  Shaw, Leslee J ^a   Hage, Fadi G ^b,c   Berman, Daniel S ^d   Hachamovitch, Rory ^e   Iskandrian, Ami ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; EXERCISE TEST; HEART RATE; HUMAN; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARDIOLOGY; COMPARATIVE EFFECTIVENESS RESEARCH; EXERCISE TEST; HEART RATE; HUMANS; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84868209938     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-012-9605-y     Document Type: Erratum

References (163)

1. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004;11:171-85.
2. Levin DC, Intenzo CM, Rao VM, Frangos AJ, Parker L, Sunshine JH. Comparison of recent utilization trends in radionuclide myocardial perfusion imaging among radiologists and cardiologists. J Am Coll Radiol 2005;2:821-4.
3. Shaw LJ, Marwick TH, Zoghbi WA, Hundley WG, Kramer CM, Achenbach S, et al. Why all the focus on cardiac imaging? JACC Cardiovasc Imaging 2010;3:789-94.
4. Shaw LJ, Min JK, Hachamovitch R, Peterson ED, Hendel RC, Woodard PK, et al. Cardiovascular imaging research at the crossroads. JACC Cardiovasc Imaging 2010;3:316-24.
5. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91.
6. http://www.commonwealthfund.org/Publications/Fund-Reports/ 2007/Jan/Slowing-the-Growth-of-U-S-Health-Care-Expenditures-What-Are-the- Options.aspx. Accessed May 10 2012.
7. Levin DC, Rao VM, Parker L, Frangos AJ, Sunshine JH. Recent trends in utilization of cardiovascular imaging: How important are they for radiology? J Am Coll Radiol 2005;2:736-9.
8. Levin DC, Rao VM, Parker L, Frangos AJ, Sunshine JH. Recent shifts in place of service for noninvasive diagnostic imaging: Have hospitals missed an opportunity? J Am Coll Radiol 2009;6:96-9.
9. www.cms.gov/DataCompendium/. Accessed May 10 2012.
10. Shaw LJ. The importance of patient-centred imaging. Can J Cardiol 2012;28:9-10.
11. http://www.kaiseredu.org/Issue-Modules/US-Health-Care-Costs/ Background-Brief.aspx#footnote5. Accessed May 10 2012.
12. Grady D, Redberg RF. Less is more: How less health care can result in better health. Arch Intern Med 2010;170:749-50.
13. Hendel RC, Patel MR, Kramer CM, Poon M, Carr JC, Gerstad NA, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006;48:1475-97.
14. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/ SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, The American Society of Nuclear Cardiology, The American College of Radiology, The American Heart Association, The American Society of Echocardiography, The Society of Cardiovascular Computed Tomography, The Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol 2009;53:2201-29.
15. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur SR, Reddy P, Carlos RC. Diagnostic performance of positron emission tomography in the detection of coronary artery disease: A metaanalysis. Acad Radiol 2008;15:444-51.
16. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: The evidence. Eur J Nucl Med Mol Imaging 2004;31:261-91.
17. Hamon M, Fau G, Nee G, Ehtisham J, Morello R. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 2010;12:29.
18. Bettencourt N, Rocha J, Ferreira N, Pires-Morais G, Carvalho M, Leite D, et al. Incremental value of an integrated adenosine stress-rest MDCT perfusion protocol for detection of obstructive coronary artery disease. J Cardiovasc Comput Tomogr 2011;5:392-405.
19. Feuchtner G, Goetti R, Plass A, Wieser M, Scheffel H, Wyss C, et al. Adenosine stress high-pitch 128-slice dual-source myocardial computed tomography perfusion for imaging of reversible myocardial ischemia: Comparison with magnetic resonance imaging. Circ Cardiovasc Imaging 2011;4:540-9.
20. Cury RC, Magalhaes TA, Borges AC, Shiozaki AA, Lemos PA, Junior JS, et al. Dipyridamole stress and rest myocardial perfusion by 64-detector row computed tomography in patients with suspected coronary artery disease. Am J Cardiol 2010;106:310-5.
21. Rocha-Filho JA, Blankstein R, Shturman LD, Bezerra HG, Okada DR, Rogers IS, et al. Incremental value of adenosineinduced stress myocardial perfusion imaging with dual-source CT at cardiac CT angiography. Radiology 2010;254:410-9.
22. Blankstein R, Shturman LD, Rogers IS, Rocha-Filho JA, Okada DR, Sarwar A, et al. Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography. J Am Coll Cardiol 2009;54:1072-84.
23. Dorbala S, Beller GA, Shaw LJ, Udelson JE, Iskandrian AE. Advancing the research mission of ASNC. J Nucl Cardiol 2011;18:534-5.
24. Bourque JM, Beller GA. Stress myocardial perfusion imaging for assessing prognosis: An update. JACC Cardiovasc Imaging 2011;4:1305-19.
25. Berman DS, Shaw LJ, Min JK, Hachamovitch R, Abidov A, Germano G, et al. SPECT/PET myocardial perfusion imaging versus coronary CT angiography in patients with known or suspected cad. Q J Nucl Med Mol Imaging 2010;54:177-200.
26. Naya M, Di Carli MF. Myocardial perfusion PET/CT to evaluate known and suspected coronary artery disease. Q J Nucl Med Mol Imaging 2010;54:145-56.
27. Mudrick DW, Velazquez E, Borges-Neto S. Does myocardial perfusion imaging provide incremental prognostic information to left ventricular ejection fraction? Curr Cardiol Rep 2010;12:155-61.
28. Hatta T, Nishimura S, Nishimura T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging 2009;36:1835-41.
29. Momose M, Nakajima K, Nishimura T. Prognostic significance of stress myocardial gated SPECT among Japanese patients referred for coronary angiography: A study of data from the jaccess database. Eur J Nucl Med Mol Imaging 2009;36:1329-37.
30. Hakeem A, Bhatti S, Dillie KS, Cook JR, Samad Z, Roth-Cline MD, et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation 2008;118:2540-9.
31. Okuyama C, Nakajima K, Hatta T, Nishimura S, Kusuoka H, Yamashina A, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for patients with diabetes and chronic kidney disease. Nucl Med Commun 2011;32:913-9.
32. Al-Mallah MH, Hachamovitch R, Dorbala S, Di Carli MF. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction. Circ Cardiovasc Imaging 2009;2:429-36.
33. Nakata T, Hashimoto A, Wakabayashi T, Kusuoka H, Nishimura T. Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the j-access database. JACC Cardiovasc Imaging 2009;2:1393-400.
34. Hachamovitch R, Kang X, Amanullah AM, Abidov A, Hayes SW, Friedman JD, et al. Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly. Circulation 2009;120:2197-206.
35. Kang X, Shaw LJ, Hayes SW, Hachamovitch R, Abidov A, Cohen I, et al. Impact of body mass index on cardiac mortality in patients with known or suspected coronary artery disease undergoing myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 2006;47:1418-26.
36. Duvall WL, Croft LB, Corriel JS, Einstein AJ, Fisher JE, Haynes PS, et al. SPECT myocardial perfusion imaging in morbidly obese patients: Image quality, hemodynamic response to pharmacologic stress, and diagnostic and prognostic value. J Nucl Cardiol 2006;13:202-9.
37. Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Biagini E, et al. Prognostic stratification of obese patients by stress 99mtc-tetrofosmin myocardial perfusion imaging. J Nucl Med: Off Publ Soc Nucl Med 2006;47:1302-6.
38. Barmpouletos D, Stavens G, Ahlberg AW, Katten DM, O'Sullivan DM, Heller GV. Duration and type of therapy for diabetes: Impact on cardiac risk stratification with stress electrocardiographic-gated SPECT myocardial perfusion imaging. J Nucl Cardiol 2010;17:1041-9.
39. Shaw LJ, Berman DS, Hendel RC, Alazraki N, Krawczynska E, Borges-Neto S, et al. Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus. Am J Cardiol 2006;97:1538-44.
40. Matsuo S, Nakajima K, Yamasaki Y, Kashiwagi A, Nishimura T. Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese asymptomatic patients with type 2 diabetes-a study based on the j-access-2 database. Circ J 2010;74:1916-21.
41. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The diad study: A randomized controlled trial. JAMA 2009;301:1547-55.
42. Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125-33.
43. Hachamovitch R, Berman DS, Kiat H, Cohen I, Friedman JD, Shaw LJ. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: An evaluation of incremental prognostic value and cost-effectiveness. Circulation 2002;105:823-9.
44. Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-40.
45. Shaw LJ, Hachamovitch R, Heller GV, Marwick TH, Travin MI, Iskandrian AE, et al. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The economics of noninvasive diagnosis (end) study group. Am J Cardiol 2000;86:1-7.
46. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.
47. Machecourt J, Longere P, Fagret D, Vanzetto G, Wolf JE, Polidori C, et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 1994;23:1096-106.
48. Raziei G, Tavakoli A, Seifollahi Asl S, Amoiei M, Javadi H, Assadi M. One-year prognosis of patients with normal myocardial perfusion imaging using technitium-99m sestamibi in suspected coronary artery disease: A single-center experience of 1,047 patients. Perfusion 2011;26:309-14.
49. Rozanski A, Gransar H, Hayes SW, Friedman JD, Hachamovitch R, Berman DS. Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT. J Nucl Cardiol 2010;17:999-1008.
50. Shaw LJ, Hendel RC, Cerquiera M, Mieres JH, Alazraki N, Krawczynska E, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005;45:1494-504.
51. Shaw LJ, Hendel RC, Heller GV, Borges-Neto S, Cerqueira M, Berman DS. Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT. J Nucl Cardiol 2008;15:762-73.
52. Johnson NP, Schimmel DR Jr, Dyer SP, Leonard SM, Holly TA. Survival by stress modality in patients with a normal myocardial perfusion study. Am J Cardiol 2011;107:986-9.
53. Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol 2004;11:551-61.
54. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: Evolving knowledge. J Am Coll Cardiol 2009;54:1561-75.
55. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on the management of patients with chronic stable angina). J Am Coll Cardiol 2003;41:159-68.
56. Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035-42.
57. Navare SM, Katten D, Johnson LL, Mather JF, Fowler MS, Ahlberg AW, et al. Risk stratification with electrocardiographicgated dobutamine stress technetium-99m sestamibi single-photon emission tomographic imaging: Value of heart rate response and assessment of left ventricular function. J Am Coll Cardiol 2006;47:781-8.
58. Schenker MP, Dorbala S, Hong EC, Rybicki FJ, Hachamovitch R, Kwong RY, et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: A combined positron emission tomography/computed tomography study. Circulation 2008;117:1693-700.
59. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: A report of the American College Of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol 2003;42:1318-33.
60. Bourque JM, Charlton GT, Holland BH, Belyea CM, Watson DD, Beller GA. Prognosis in patients achieving[/=10 mets on exercise stress testing: Was SPECT imaging useful? J Nucl Cardiol 2011;18:230-7.
61. Depuey EG, Mahmarian JJ, Miller TD, Einstein AJ, Hansen CL, Holly TA, et al. Patient-centered imaging. J Nucl Cardiol 2012;19:185-215.
62. Einstein AJ. Effects of radiation exposure from cardiac imaging: How good are the data? J Am Coll Cardiol 2012;59:553-65.
63. Einstein AJ, Knuuti J. Cardiac imaging: Does radiation matter? Eur Heart J 2012;33:573-8.
64. Fazel R, Dilsizian V, Einstein AJ, Ficaro EP, Henzlova M, Shaw LJ. Strategies for defining an optimal risk-benefit ratio for stress myocardial perfusion SPECT. J Nucl Cardiol 2011;18:385-92.
65. Chen J, Einstein AJ, Fazel R, Krumholz HM, Wang Y, Ross JS, et al. Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: A population-based analysis. J Am Coll Cardiol 2010;56:702-11.
66. Einstein AJ, Sanz J, Dellegrottaglie S, Milite M, Sirol M, Henzlova M, et al. Radiation dose and cancer risk estimates in 16-slice computed tomography coronary angiography. J Nucl Cardiol 2008;15:232-40.
67. Chang SM, Nabi F, Xu J, Raza U, Mahmarian JJ. Normal stressonly versus standard stress/rest myocardial perfusion imaging: Similar patient mortality with reduced radiation exposure. J Am Coll Cardiol 2010;55:221-30.
68. Duvall WL, Wijetunga MN, Klein TM, Razzouk L, Godbold J, Croft LB, et al. The prognosis of a normal stress-only tc-99m myocardial perfusion imaging study. J Nucl Cardiol 2010;17:370-7.
69. Gibson PB, Demus D, Noto R, Hudson W, Johnson LL. Low event rate for stress-only perfusion imaging in patients evaluated for chest pain. J Am Coll Cardiol 2002;39:999-1004.
70. Pazhenkottil AP, Ghadri JR, Nkoulou RN, Wolfrum M, Buechel RR, Kuest SM, et al. Improved outcome prediction by SPECT myocardial perfusion imaging after CT attenuation correction. J Nucl Med: Off Publ Soc Nucl Med 2011;52:196-200.
71. Duvall WL, Croft LB, Ginsberg ES, Einstein AJ, Guma KA, George T, et al. Reduced isotope dose and imaging time with a high-efficiency CZT SPECT camera. J Nucl Cardiol 2011;18:847-57.
72. Gimelli A, Rossi G, Landi P, Marzullo P, Iervasi G, L'Abbate A, et al. Stress/rest myocardial perfusion abnormalities by gated SPECT: Still the best predictor of cardiac events in stable ischemic heart disease. J Nucl Med: Off Publ Soc Nucl Med 2009;50:546-53.
73. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639-47.
74. Berman DS, Wong ND, Gransar H, Miranda-Peats R, Dahlbeck J, Hayes SW, et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol 2004;44:923-30.
75. Hachamovitch R, Berman DS, Kiat H, Cohen I, Lewin H, Amanullah A, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997;80:426-33.
76. Hachamovitch R, Berman DS, Morise AP, Diamond GA. Statistical, epidemiological and fiscal issues in the evaluation of patients with coronary artery disease. Q J Nucl Med 1996;40:35-46.
77. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.
78. Knuuti J, Saraste A. Advances in clinical application of quantitative myocardial perfusion imaging. J Nucl Cardiol 2012. doi: 10.1007/s12350-012-9530- 0.
79. Slomka PJ, Nishina H, Berman DS, Akincioglu C, Abidov A, Friedman JD, et al. Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol 2005;12:66-77.
80. Wolak A, Slomka PJ, Fish MB, Lorenzo S, Berman DS, Germano G. Quantitative diagnostic performance of myocardial perfusion SPECT with attenuation correction in women. J Nucl Med: Off Publ Soc Nucl Med 2008;49:915-22.
81. Wolak A, Slomka PJ, Fish MB, Lorenzo S, Acampa W, Berman DS, et al. Quantitative myocardial-perfusion SPECT: Comparison of three state-of-the-art software packages. J Nucl Cardiol 2008;15:27-34.
82. Mahmarian JJ, Dakik HA, Filipchuk NG, Shaw LJ, Iskander SS, Ruddy TD, et al. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol 2006;48:2458-67.
83. Mahmarian JJ, Shaw LJ, Filipchuk NG, Dakik HA, Iskander SS, Ruddy TD, et al. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol 2006;48:2448-57.
84. Momose M, Babazono T, Kondo C, Kobayashi H, Nakajima T, Kusakabe K. Prognostic significance of stress myocardial ECG-gated perfusion imaging in asymptomatic patients with diabetic chronic kidney disease on initiation of haemodialysis. Eur J Nucl Med Mol Imaging 2009;36:1315-21.
85. Rajagopal V, Gurm HS, Brunken RC, Pothier CE, Bhatt DL, Lauer MS. Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting. Am Heart J 2005;149:534-40.
86. Hachamovitch R, Rozanski A, Hayes SW, Thomson LE, Germano G, Friedman JD, et al. Predicting therapeutic benefit from myocardial revascularization procedures: Are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol 2006;13:768-78.
87. De Lorenzo A, Hachamovitch R, Kang X, Gransar H, Sciammarella MG, Hayes SW, et al. Prognostic value of myocardial perfusion SPECT versus exercise electrocardiography in patients with ST-segment depression on resting electrocardiography. J Nucl Cardiol 2005;12:655-61.
88. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 2005;45:722-9.
89. Shaw LJ, Min JK, Hachamovitch R, Hendel RC, Borges-Neto S, Berman DS. Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT. J Nucl Cardiol 2012;19:43-52.
90. Lee DS, Verocai F, Husain M, Al Khdair D, Wang X, Freeman M, et al. Cardiovascular outcomes are predicted by exercisestress myocardial perfusion imaging: Impact on death, myocardial infarction, and coronary revascularization procedures. Am Heart J 2011;161:900-7.
91. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. New Engl J Med 2007;356:1503-16.
92. Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. New Engl J Med 2009;360: 2503-15.
93. Moroi M, Yamashina A, Tsukamoto K, Nishimura T. Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia. Int J Cardiol 2012;158(2): 246-52.
94. Shaw LJ, Hachamovitch R, Eisenstein EL, Kesler KL, Heller GV, Miller DD. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part I. J Nucl Cardiol 1996;3:538-45.
95. Shaw LJ, Eisenstein EL, Hachamovitch R, Heller GV, Miller DD. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II. J Nucl Cardiol 1997;4:52-60.
96. Amanullah AM, Berman DS, Erel J, Kiat H, Cohen I, Germano G, et al. Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol 1998;82:725-30.
97. Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germano G, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999;138:1025-32.
98. Hachamovitch R, Shufelt C. Statistical analysis of medical data. Part I: Univariable analysis. J Nucl Cardiol 2000;7:146-52.
99. Di Carli MF, Hachamovitch R, Berman DS. The art and science of predicting postrevascularization improvement in left ventricular (LV) function in patients with severely depressed LV function. J Am Coll Cardiol 2002;40:1744-7.
100. Azarbal B, Hayes SW, Lewin HC, Hachamovitch R, Cohen I, Berman DS. The incremental prognostic value of percentage of heart rate reserve achieved over myocardial perfusion singlephoton emission computed tomography in the prediction of cardiac death and all-cause mortality: Superiority over 85% of maximal age-predicted heart rate. J Am Coll Cardiol 2004;44:423-30.
101. Lertsburapa K, Ahlberg AW, Bateman TM, Katten D, Volker L, Cullom SJ, et al. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol 2008;15:745-53.
102. Pencina MJ, D'Agostino RB Sr, Demler OV. Novel metrics for evaluating improvement in discrimination: Net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med 2012;31:101-13.
103. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the roc curve to reclassification and beyond. Stat Med 2008;27:157-72. (discussion 207-112).
104. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.
105. Shaw LJ, Wilson PW, Hachamovitch R, Hendel RC, Borges-Neto S, Berman DS. Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. JACC Cardiovasc Imaging 2010;3:1139-48.
106. Shaw LJ, Hachamovitch R, Min J, Berman DS. Importance of residual myocardial ischemia after intervention in the genesis of cardiovascular events among patients with chronic coronary artery disease. Curr Cardiol Rep 2011;13:280-6.
107. Carryer DJ, Askew JW, Hodge DO, Miller TD, Gibbons RJ. The timing and impact of follow-up studies after normal stress singlephoton emission computed tomography sestamibi studies. Circ Cardiovasc Imaging 2010;3:520-6.
108. Hage FG, Iskandrian AE. Heart rate response during vasodilator stress myocardial perfusion imaging: Mechanisms and implications. J Nucl Cardiol 2010;17:536-9.
109. Hage FG, Dean P, Bhatia V, Iqbal F, Heo J, Iskandrian AE. The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease. Am Heart J 2011;162:356-62.
110. Mathur S, Shah AR, Ahlberg AW, Katten DM, Heller GV. Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging. J Nucl Cardiol 2010;17:617-24.
111. Hage FG, Dean P, Iqbal F, Heo J, Iskandrian AE. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging. J Nucl Cardiol 2011;18(6):1086-94.
112. Iqbal F, Al Jaroudi W, Mallela R, Heo J, Iskandrian AE, Hage FG. Net reclassification improvement of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress. J Am Coll Cardiol 2012;59: 1106-352. A1324.
113. Sarwar A, Shaw LJ, Shapiro MD, Blankstein R, Hoffmann U, Cury RC, et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging 2009;2:675-88.
114. Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA, Berman D, et al. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging 2009;2:692-700.
115. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:e50-103.
116. Pazhenkottil AP, Nkoulou RN, Ghadri JR, Herzog BA, Buechel RR, Kuest SM, et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur Heart J 2011;32:1465-71.
117. Pazhenkottil AP, Nkoulou RN, Ghadri JR, Herzog BA, Kuest SM, Husmann L, et al. Impact of cardiac hybrid single-photon emission computed tomography/computed tomography imaging on choice of treatment strategy in coronary artery disease. Eur Heart J 2011;32:2824-9.
118. Gaemperli O, Bengel FM, Kaufmann PA. Cardiac hybrid imaging. Eur Heart J 2011;32:2100-8.
119. Bybee KA, Lee J, Markiewicz R, Longmore R, McGhie AI, O'Keefe JH, et al. Diagnostic and clinical benefit of combined coronary calcium and perfusion assessment in patients undergoing PET/CT myocardial perfusion stress imaging. J Nucl Cardiol 2010;17:188-96.
120. Herzog BA, Husmann L, Landmesser U, Kaufmann PA. Lowdose computed tomography coronary angiography and myocardial perfusion imaging: Cardiac hybrid imaging below 3msv. Eur Heart J 2009;30:644.
121. van Werkhoven JM, Schuijf JD, Gaemperli O, Jukema JW, Boersma E, Wijns W, et al. Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 2009;53:623-32.
122. vanWerkhoven JM, de Boer SM, Schuijf JD, Cademartiri F,Maffei E, Jukema JW, et al. Impact of clinical presentation and pretest likelihood on the relation between calcium score and computed tomographic coronary angiography.AmJ Cardiol 2010;106:1675-9.
123. Senthamizhchelvan S, Bravo PE, Lodge MA, Merrill J, Bengel FM, Sgouros G. Radiation dosimetry of 82rb in humans under pharmacologic stress. J Nucl Med: Off Publ Soc Nucl Med 2011;52:485-91.
124. Einstein AJ. Radiation risk from cardiac CT and nuclear cardiology: Addressing concerns with innovative solutions. J Nucl Cardiol 2011;18:561.
125. Yoshinaga K, Chow BJ, Williams K, Chen L, deKemp RA, Garrard L, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 2006;48:1029-39.
126. Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011;58:740-8.
127. Tio RA, Dabeshlim A, Siebelink HM, de Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med: Off Publ Soc Nucl Med 2009;50:214-9.
128. Fukushima K, Javadi MS, Higuchi T, Lautamaki R, Merrill J, Nekolla SG, et al. Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82rb PET perfusion imaging. J Nucl Med 2011;52:726-32.
129. Van Tosh A, Supino PG, Nichols KJ, Garza D, Horowitz SF, Reichek N. Prognosis of a normal positron emission tomography 82rb myocardial perfusion imaging study in women with no history of coronary disease. Cardiology 2010;117:301-6.
130. Chow BJ, Al Shammeri OM, Beanlands RS, Chen L, deKemp RA, DaSilva J, et al. Prognostic value of treadmill exercise and dobutamine stress positron emission tomography. Can J Cardiol 2009;25:e220-4.
131. Dorbala S, Hachamovitch R, Curillova Z, Thomas D, Vangala D, Kwong RY, et al. Incremental prognostic value of gated rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging 2009;2:846-54.
132. Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: A metaanalysis. J Am Coll Cardiol 2007;49:227-37.
133. Daniele S, Nappi C, Acampa W, Storto G, Pellegrino T, Ricci F, et al. Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography. J Nucl Cardiol 2011;18:612-9.
134. Slomka PJ, Alexanderson E, Jacome R, Jimenez M, Romero E, Meave A, et al. Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13N-ammonia PET/CT. J Nucl Med 2012;53:171-81.
135. Schelbert HR. Positron emission tomography measurements of myocardial blood flow: Assessing coronary circulatory function and clinical implications. Heart 2012;98:592-600.
136. Schelbert HR. Anatomy and physiology of coronary blood flow. J Nucl Cardiol 2010;17:545-54.
137. Hachamovitch R, Nutter B, Hlatky MA, Shaw LJ, Ridner ML, Dorbala S, et al. Patient management after noninvasive cardiac imaging results from sparc (study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol 2012;59:462-74.
138. Califf RM, Armstrong PW, Carver JR, D'Agostino RB, Strauss WE 27th
139. Shaw LJ, Cerqueira MD, Brooks MM, Althouse AD, Sansing VV, Beller GA, et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: Results from the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial. J Nucl Cardiol 2012. [Epub ahead of print].
140. Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. New Engl J Med 2011;364:1617-25.
141. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. New Engl J Med 2011;364:1607-16.
142. Beanlands RS, Ruddy TD, Freeman M, Nichol G. Patient management guided by viability imaging. J Am Coll Cardiol 2001;38:1271-3.
143. Shukla T, Nichol G, Wells G, deKemp RA, Davies RA, Haddad H, et al. Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trial. Can J Cardiol 2012;28:54-61.
144. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007;50:2002-12.
145. D'Egidio G, Nichol G, Williams KA, Guo A, Garrard L, deKemp R, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: A substudy of the PARR-2 trial. JACC Cardiovasc Imaging 2009;2:1060-8.
146. Abraham A, Nichol G, Williams KA, Guo A, deKemp RA, Garrard L, et al. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: The Ottawa-five substudy of the PARR 2 trial. J Nucl Med 2010;51:567-74.
147. Soman P, Lahiri A, Mieres JH, Calnon DA, Wolinsky D, Beller GA, et al. Etiology and pathophysiology of new-onset heart failure: Evaluation by myocardial perfusion imaging. J Nucl Cardiol 2009;16:82-91.
148. Golub RM, Fontanarosa PB. Comparative effectiveness research: Relative successes. JAMA 2012;307:1643-5.
149. Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI). Methodological standards and patient-centeredness in comparative effectiveness research: The PCORI perspective. JAMA 2012;307:1636-40.
150. Shaw LJ, Mieres JH, Hendel RH, Boden WE, Gulati M, Veledar E, et al. Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: Results from the what is the optimal method for ischemia evaluation in women (women) trial. Circulation 2011;124:1239-49.
151. Udelson JE, Beshansky JR, Ballin DS, Feldman JA, Griffith JL, Handler J, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: A randomized controlled trial. JAMA 2002;288:2693-700.
152. Hoffmann U, Bamberg F, Chae CU, Nichols JH, Rogers IS, Seneviratne SK, et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: The ROMICAT (rule out myocardial infarction using computer assisted tomography) trial. J Am Coll Cardiol 2009;53:1642-50.
153. Goldstein JA, Chinnaiyan KM, Abidov A, Achenbach S, Berman DS, Hayes SW, et al. The CT-STAT (coronary computed tomographic angiography for systematic triage of acute chest pain patients to treatment) trial. J Am Coll Cardiol 2011;58:1414-22.
154. Goldstein JA, Gallagher MJ, O'Neill WW, Ross MA, O'Neil BJ, Raff GL. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol 2007;49:863-71.
155. Schlett CL, Banerji D, Siegel E, Bamberg F, Lehman SJ, Ferencik M, et al. Prognostic value of CT angiography for major adverse cardiac events in patients with acute chest pain from the emergency department: 2-year outcomes of the ROMICAT trial. JACC Cardiovasc Imaging 2011;4:481-91.
156. Koo BK, Erglis A, Doh JH, Daniels DV, Jegere S, Kim HS, et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter discover-flow (diagnosis of ischemia-causing stenoses obtained via noninvasive fractional flow reserve) study. J Am Coll Cardiol 2011;58:1989-97.
157. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, et al. Cardiovascular magnetic resonance and singlephoton emission computed tomography for diagnosis of coronary heart disease (CE-MARC): A prospective trial. Lancet 2012;379:453-60.
158. https://www.promisetrial.org. Accessed May 10 2012.
159. http://www.rescuetrial.org. Accessed May 10 2012.
160. https://www.ischemiatrial.org. Accessed May 10 2012.
161. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. Medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012-24.
162. Lloyd-Jones DM, Dyer AR, Wang R, Daviglus ML, Greenland P. Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry). Am J Cardiol 2007;99:535-40.
163. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, et al. Age-and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the international multicenter confirm (coronary CT angiography evaluation for clinical outcomes: An international multicenter registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 2011;58:849-60.